Combination therapy response biomarke...

Combination therapy response biomarkers of colorectal cancer

Posted in the Colon Cancer Forum


Madison, WI

#1 Feb 21, 2012
According to this recent US patent application, high pretreatment plasma YKL-40 and serum YKL-40 levels were prognostic biomarkers of short overall survival in two independent studies of patients with metastatic colorectal cancer treated with third-line cetuximab in combination with irinotecan. Details:

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Colon Cancer Discussions

Title Updated Last By Comments
can viagra make you go deaf? Apr '16 Wyatt 1
viagra's hidden uses: diet pill, cancer fighter? Mar '16 Howard 1
News Testing, knowledge key to detecting colon cancer Mar '16 huey goins 2
News WGRZ News - Colon Cancer: One Man's Fight (Mar '08) Jan '16 chris 15
Namber Of Plyps Dec '15 Amy 2
Colon' back passage conditions including cancer' (Sep '15) Sep '15 langham research ... 1
News The 10 commandments of cancer prevention (May '09) Sep '15 Stinky Pete 28
More from around the web